Valuation Nectar Lifesciences Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 12:05:09 19/06/2026 BST			5-day change	1st Jan Change
11.44 ^INR	-1.63%		-1.29%	-41.06%

05-30	Nectar Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03-05	Nectar Lifesciences Limited completed the acquisition of Avensis Exports Private Limited.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,198	4,171	5,393	3,577	6,761	5,147
Change	-	89.8%	29.3%	-33.68%	89.03%	-23.88%
Enterprise Value (EV) ¹	9,771	12,945	13,810	10,936	12,914	10,769
Change	-	32.49%	6.68%	-20.81%	18.08%	-16.6%
P/E	6.91x	-5.69x	21.5x	-14.8x	137x	-4.53x
PBR	0.19x	0.39x	0.5x	0.34x	0.63x	0.54x
PEG	-	0x	-0x	0x	-1x	0x
Capitalization / Revenue	0.09x	0.27x	0.32x	0.23x	0.4x	0.31x
EV / Revenue	0.41x	0.84x	0.83x	0.72x	0.77x	0.64x
EV / EBITDA	4.44x	11.7x	8.71x	20.3x	8.41x	-41.3x
EV / EBIT	6.13x	25.9x	13.6x	-211x	13.9x	-12.2x
EV / FCF	7.5x	6.19x	-28.1x	42.1x	13.3x	-63x
FCF Yield	13.3%	16.2%	-3.56%	2.37%	7.52%	-1.59%
Dividend per Share ²	0.05	-	-	-	-	-
Rate of return	0.51%	-	-	-	-	-
EPS ²	1.418	-3.27	1.117	-1.08	0.22	-5.07
Distribution rate	3.53%	-	-	-	-	-
Net sales ¹	23,664	15,433	16,689	15,237	16,846	16,704
EBITDA ¹	2,201	1,102	1,586	539.5	1,536	-260.8
EBIT ¹	1,593	499.9	1,016	-51.73	928.4	-884.7
Net income ¹	317.9	-732.6	250.5	-241.8	49.95	-1,137
Net Debt ¹	7,573	8,774	8,417	7,359	6,152	5,623
Reference price ²	9.80	18.60	24.05	15.95	30.15	22.95
Nbr of stocks (in thousands)	224,261	224,261	224,261	224,261	224,261	224,261
Announcement Date	14/08/20	24/08/21	24/08/22	11/08/23	14/08/24	26/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NECTAR LIFESCIENCES LIMITED	-	-	-	-	23.55M
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.92x	7.19x	24.5x	0.82%	46.74B
OTSUKA HOLDINGS CO., LTD.	17.48x	1.96x	9.26x	1.38%	34.33B
CIPLA LIMITED	26.09x	3.2x	16.38x	0.92%	11.57B
ZYDUS LIFESCIENCES LIMITED	23.48x	4.1x	15.27x	0.76%	11.42B
KRKA, D. D.	19.63x	3.39x	12.31x	3.48%	9.09B
GEDEON RICHTER	8.19x	1.92x	5.02x	5.29%	6.98B
ONO PHARMACEUTICAL CO., LTD.	15.23x	1.9x	6.52x	3.48%	6.55B
GLENMARK PHARMACEUTICALS LIMITED	33.6x	3.82x	16.27x	0.24%	6.62B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	40.51x	-	-	-	5B
Average	24.68x	3.43x	13.19x	2.05%	13.83B
Weighted average by Cap.	26.77x	4.27x	15.94x	1.48%